Delivery Order SPE2DR25D7066-SPE2DR26F7ZWT
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valganciclovir HCL 50 mg/ml (88 ml) on August 11, 2025, with a ceiling value of $1,024.62. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a contract ceiling value of $8,470.02 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Valganciclovir HCL 50 mg/ml in an 88ml unit, valued at $3,439.80 under firm fixed pricing. This delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a ceiling value of $1,115.64 and a firm fixed price structure. The order is scheduled for completion by December 15, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania location. This is a non-set-aside competitive award, issued as a delivery order under an existing contract vehicle,...
- The Defense Logistics Agency awarded a delivery order valued at $4,120.32 to AmerisourceBergen Drug Corp for the supply of Valganciclovir HCL 50 mg/ml in an 88ml formulation. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, issued on September 10, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Valganciclovir 450 mg tablets (60-count units) with a ceiling value of $2,163.72. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, serving as the prime contractor on...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 60 count bottles of 450 mg valganciclovir tablets. This $2,050.03 award has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and provides a wide range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units) under a firm fixed price contract valued at $23,621.97, with an ultimate completion date of September 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,832.16 to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units) under a firm fixed price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a competitively awarded, non-set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...